NCT04565886

Brief Summary

Peri-implantitis is a pathological condition occurring in tissues around dental implants, characterized by inflammation in the peri-implant connective tissue and progressive loss of supporting bone. The goals of peri-implantitis treatment is the resolution of peri-implant soft tissue inflammation and stabilization of the bony attachment (e.g., the level of osseointegration). For this decontamination of the implant surface is mandatory. In order to increase implant surface decontamination, several adjunctive tools have been proposed and investigated both in pre-clinical and clinical studies such as the use of photodynamic therapy and lasers. So far, no data are available to clearly demonstrate the efficacy of the adjunctive use of a diode laser in the non-surgical treatment of peri-implantitis. Therefore, the aim of the present randomized controlled trial (RCT) is to investigate the adjunctive effect of the application of a diode laser to treat peri-implantitis lesions by means of a non-surgical approach. A total of 30 patients is randomly allocated to two groups. The test group receives 3 x nonsurgical mechanical treatment with diode laser application whereas the control group receives the same treatment with sham laser application. The primary outcome is the peri-implant pocket probing depth at 12 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 25, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

1.7 years

First QC Date

September 22, 2020

Last Update Submit

August 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in peri-implant pocket probing depth (PPD)

    the difference between baseline PPD and PPD after 12 months

    at 12 months

Secondary Outcomes (8)

  • Change at deepest PPD (mm)

    at 12 months

  • Change in probing attachment level (PAL) (mm)

    at 12 months

  • Change in the % of implants with BoP / SUP

    at 12 months

  • Mean radiographic bone fill (mm) at mesial and distal sites

    at 12 months

  • Change in width of keratinized mucosa (KM) (mm)

    at 12 months

  • +3 more secondary outcomes

Study Arms (2)

control

SHAM COMPARATOR

Non-surgical mechanical instrumentation 3x. Each time the laser will be held in place but will not be activated.

Device: Sham Diode laser

laser

EXPERIMENTAL

Non-surgical mechanical instrumentation 3x with adjunctive diode laser application according to the protocol of the Department of Periodontology, University of Bern

Device: Diode laser application

Interventions

After mechanical debridement, the pockets around the implant will be rinsed with sterile saline solution. Adjunctive diode laser (settings: 810 nm, 2.5 W, 50 Hz, 10 ms) will be applied 3x for 30 s (i.e., 90 s per appointment) using a 400-lm thick fiber (WhiteStar, Orcos Medical AG, Küsnacht, Switzerland) in the test group. In the control group, non-activated (= placebo) adjunctive diode laser will be applied. The entire treatment procedure, including mechanical debridement, will be performed at Day 0 (= baseline), 7 and 14. The laser decontamination procedure will occur by systematically moving the laser tip along the subgingival implant surface in a vertical and horizontal scanning way. The laser tip will be checked after 4-5 s for coagulation to prevent hotspots in the soft tissues.

laser

After mechanical debridement, the pockets around the implant will be rinsed with sterile saline solution. Non-activated (= placebo) adjunctive diode laser will be applied. The entire treatment procedure, including mechanical debridement, will be performed at Day 0 (= baseline), 7 and 14. The laser decontamination procedure will occur by systematically moving the laser tip along the subgingival implant surface in a vertical and horizontal scanning way.

control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • systemically healthy patients enrolled in regular supportive periodontal therapy (SPT)
  • Tissue level (TL) implants with an SLA surface supporting single-unit crowns (SUCs) or fixed dental prostheses (FDPs)
  • Pocket Probing Depth (PPD) \> 5 mm
  • Presence of BoP and /or SU
  • Radiographic evidence of crestal bone loss ≤ 2mm based on periapical radiographs after delivery of the final restoration
  • Cleansable cemented or screw-retained restoration
  • Presence of at least 2 mm of keratinized and attached mucosa (KM)
  • Signed informed consent

You may not qualify if:

  • Systemic diseases that could interfere with the treatment outcome (e.g. uncontrolled diabetes mellitus, chemotherapy, etc.)
  • Previous peri-implantitis treatment
  • Full-Mouth Plaque Score (FMPS) \> 25%
  • Full-Mouth Bleeding Score (FMBS) \> 25%
  • Cigarette smoking \> 10 cig./day
  • Removable implant-supported restorations
  • Implant mobility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Periodontology, University of Bern

Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised placebo controlled monocentric trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2020

First Posted

September 25, 2020

Study Start

December 1, 2019

Primary Completion

August 1, 2021

Study Completion

July 1, 2022

Last Updated

August 9, 2022

Record last verified: 2022-08

Locations